Literature DB >> 24476543

Structural factors affecting cytotoxic activity of (E)-1-(Benzo[d ][1,3]oxathiol-6-yl)-3-phenylprop-2-en-1-one derivatives.

Marek T Konieczny1, Anita Bułakowska, Justyna Polak, Danuta Pirska, Wojciech Konieczny, Patrycja Gryń, Andrzej Skladanowski, Michał Sabisz, Krzysztof Lemke, Anna Pieczykolan, Marlena Gałązka, Katarzyna Wiciejowska, Joanna Wietrzyk.   

Abstract

Derivatives of (E)-1-(5-alkoxybenzo[d][1,3]oxathiol-6-yl)-3-phenylprop-2-en-1-one demonstrated exceptionally high in vitro cytotoxic activity, with IC50 values of the most active derivatives in the nanomolar range. To identify structural fragments necessary for the activity, several analogs deprived of selected fragments were prepared, and their cytotoxic activity was tested. It was found that the activity depends on combined effects of (i) the heterocyclic ring, (ii) the alkoxy group at position 5 of the benzoxathiole ring, and (iii) the substituents in the phenyl ring B. Replacement of the sulfur atom by oxygen does not influence the activity. None of the listed structural fragments alone assured high cytotoxic activity.
© 2014 John Wiley & Sons A/S.

Entities:  

Keywords:  SAR; benzoxathiole; chalcone; cytotoxic activity; structure optimization

Mesh:

Substances:

Year:  2014        PMID: 24476543     DOI: 10.1111/cbdd.12296

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  3 in total

Review 1.  Chalcone: A Privileged Structure in Medicinal Chemistry.

Authors:  Chunlin Zhuang; Wen Zhang; Chunquan Sheng; Wannian Zhang; Chengguo Xing; Zhenyuan Miao
Journal:  Chem Rev       Date:  2017-05-10       Impact factor: 60.622

2.  Pharmacokinetic Studies of Oxathio-Heterocycle Fused Chalcones.

Authors:  Krystyna Okoniewska; Marek T Konieczny; Krzysztof Lemke; Tomasz Grabowski
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

3.  Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on MCF-7 breast cancer cells by targeting tubulin colchicine binding site.

Authors:  Guangcheng Wang; Wenjing Liu; Zipeng Gong; Yong Huang; Yongjun Li; Zhiyun Peng
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.